Form 4: SCYNEXIS INC Director Armando Anido Acquires Shares and Options
SEC Form 4 Filing
Director Armando Anido acquired 23,000 shares of common stock and 23,000 stock options in SCYNEXIS INC on June 20, 2024.
Summary
- On June 20, 2024, Armando Anido, a director of SCYNEXIS INC, acquired 23,000 shares of common stock.
- These shares were acquired at a price of $0.00.
- Following the transaction, Anido directly owns 48,000 shares of common stock.
- Anido also acquired 23,000 stock options with an exercise price of $1.88, vesting on June 19, 2025, and expiring on June 19, 2034.
- These options also vest on the first anniversary of the grant date, contingent upon continuous service as a non-employee director.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating a director's acquisition of shares and options, which could be interpreted as a positive sign of confidence, but it's not definitively bullish.
Positives
- The acquisition of shares and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of the stock options is contingent upon continuous service as a non-employee director.
Industry Context
This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency regarding the trading activities of company directors and officers.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading.
- Similar filings are made by directors and officers of companies like Pfizer, Merck, and Johnson & Johnson when they buy or sell shares of their respective companies.
- The vesting schedules and exercise prices of stock options are generally comparable to industry standards for executive compensation.
Stakeholder Impact
- The acquisition of shares and options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 06/19/2025 | Vesting date for the stock options. |
| 06/19/2034 | Expiration date for the stock options. |
| 06/21/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.